These included evaluating the effect of supervised exercise training, or a specific supplement administration, to decrease the risk of sarcopenia after BS, and proposed assessing the levels of myokines, insulin resistance and patients’ quality of life, among other measurements [39–44]. The gene discussed is INS; the disease is sarcopenia.